Ascendis Pharma A/S (ASND) Competitors

Takeda Pharmaceutical (NYSE:TAK) and Ascendis Pharma A/S (NASDAQ:ASND) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Which has more volatility & risk, TAK or ASND?

Takeda Pharmaceutical has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Do analysts rate TAK or ASND?

Ascendis Pharma A/S has a consensus target price of $244.36, suggesting a potential upside of 19.75%. Given Ascendis Pharma A/S's stronger consensus rating and higher possible upside, analysts clearly believe Ascendis Pharma A/S is more favorable than Takeda Pharmaceutical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Takeda Pharmaceutical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ascendis Pharma A/S	1 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.88

Is TAK or ASND more profitable?

Takeda Pharmaceutical has a net margin of 3.20% compared to Ascendis Pharma A/S's net margin of -54.94%. Takeda Pharmaceutical's return on equity of 10.50% beat Ascendis Pharma A/S's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Takeda Pharmaceutical	3.20%	10.50%	5.10%
Ascendis Pharma A/S	-54.94%	N/A	-24.31%

Do insiders & institutionals hold more shares of TAK or ASND?

9.2% of Takeda Pharmaceutical shares are owned by institutional investors. 0.0% of Takeda Pharmaceutical shares are owned by company insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has stronger valuation & earnings, TAK or ASND?

Takeda Pharmaceutical has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Takeda Pharmaceutical	$30.09B	1.55	$712.33M	$0.30	48.72
Ascendis Pharma A/S	$393.54M	31.99	-$409.12M	-$5.16	-39.54

Does the media prefer TAK or ASND?

In the previous week, Takeda Pharmaceutical had 2 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 5 mentions for Takeda Pharmaceutical and 3 mentions for Ascendis Pharma A/S. Ascendis Pharma A/S's average media sentiment score of 0.43 beat Takeda Pharmaceutical's score of -0.17 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Takeda Pharmaceutical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ascendis Pharma A/S	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Takeda Pharmaceutical beats Ascendis Pharma A/S on 9 of the 16 factors compared between the two stocks.